Alpha-9 Oncology (Series C)

Funding Details
Date Award
June 09, 2025
Vertical
Biotechnology
Funding URL
View Funding Page
Funding Amount:
$175,000,000

Company Info
Company Description
Alpha-9 Oncology is a startup developing radioactive drugs designed to target and kill cancer cells in the kidney and prostate.
Market
Cancer treatment
Location
Boston, Massachusetts, United States
Coinvestors
Lightspeed Venture Partners, Ascenta Capital, General Catalyst, Andreessen Horowitz, RA Capital Management, Janus Henderson Investors, Delos Capital, Digitalis Ventures, Lumira Ventures, abrdn

Links